Chas Taylor

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Sword Diagnostics, Inc. provides next generation detection technology to life scientists. It offers IL-22, IL-1Beta, IL-33, IL-23 and ELISA boosters. The company was founded by David Dingott in 2004 and is headquartered in Summit Argo, IL.

Crux Biomedical, Inc. develops and manufactures medical devices. The company was founded by Thomas Fogarty and Frank Arko in August 2004 and is headquartered in San Diego, CA.

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

Bacchus Vascular, Inc. manufactures and sells medical devices. It provides treatments for peripheral vascular diseases. The company was founded by Nellix Michael and Thomas J. Fogarthy in 1999 and is headquartered in Santa Clara, CA.

Part of Mitsubishi Electric Corp., Mitsubishi Semiconductor America, Inc. is a company based in Durham, NC.

InterVene, Inc. develops non-implantable, catheter-based vein valve creation therapy. Its BlueLeaf endovenous valve formation system allows physicians to create new vein valves for patients who are unable to efficiently pump blood out of their legs and back to their heart. The company was founded by Fletcher Wilson in 2011 and is headquartered in South San Francisco, CA.

Vesteck, Inc. is an early-stage medical device company that focuses on bringing their proprietary technology to the aortic repair and structural heart markets. The company is based in West Chester, PA. The company's first product, the "suture-tight"™ nitinol suture delivery catheter, comes preloaded with 4 pairs of nitinol sutures, securing evar grafts to the aorta on initial implant or during repair procedures. The company was founded in 2019 by John Edoga, Thierry Richard. The CEO is Joseph W. Rafferty.